Last reviewed · How we verify

NCT07318077

Radicle GI Health DBG: A Study Assessing the Impact of Health and Wellness Products on GI Health and Related Health Outcomes

Recruiting now NA Last updated 23 January 2026
What this trial tests

NA trial testing GI Health Product Placebo Control in Belly Pain in 825 participants. Currently enrolling.

Timeline
6 January 2026
Primary endpoint
13 January 2027
13 January 2027

Quick facts

Lead sponsorRadicle Science
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeother
Enrollment825
Start date6 January 2026
Primary completion13 January 2027
Estimated completion13 January 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Radicle Science — full company profile →

Who can join

Adults 21 to 105, any sex, with Belly Pain or GI Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Radicle GI Health DBG: A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on GI health and related health outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of GI Health Active Product 1

Trials testing the same drug.

Other Radicle Science trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07318077.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing